DC
BIO icon

Davenport & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History

Davenport & Co’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,719
Closed -$1.14M – 1231
2025
Q2 		$1.14M Sell
4,719
-91,886
-95% -$21.7M 0.01% 656
2025
Q1 		$23.5M Buy
96,605
+11,928
+14% +$3.59M 0.14% 146
2024
Q4 		$27.8M Buy
84,677
+27,780
+49% +$9.43M 0.16% 131
2024
Q3 		$19M Buy
56,897
+590
+1% +$187K 0.11% 157
2024
Q2 		$15.4M Buy
56,307
+11,954
+27% +$3.48M 0.1% 169
2024
Q1 		$15.3M Buy
+44,353
New +$14.6M 0.1% 172
2022
Q1 		– Sell
-288
Closed -$218K – 1065
2021
Q4 		$218K Hold
288
– – ﹤0.01% 1004
2021
Q3 		$215K Buy
+288
New +$216K ﹤0.01% 956

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return